Indego® Clinical Trials at Shepherd Center

Indego® is a powered, lower limb exoskeleton developed by Parker Hannifin. It enables people with spinal cord injury (SCI) and stroke to walk and participate in over-ground gait training.  It has been FDA approved for clinical use for individuals with C7 and below SCI, as well as for individuals with hemiplegia due to stroke. It has been approved for personal use by people with T3 and below SCI.

Clinical Trials

Shepherd Center is the leading clinical partner for Parker Hannifin.  No current studies are being conducted with Indego, but future studies may be conducted using Indego with people with SCI, stroke and/or other neurological diagnoses. If you would like to be considered for participation in any upcoming study with Indego, please register using our clinical trials intake form below.  

If you are selected to be further evaluated for trials, a member of the Indego team will contact you directly. If selected, participants do not receive a stipend or payment. Participants are responsible for all travel and housing expenses during the training. Discounted hotels in the area are available.  

If you have already registered, rest assured we have received your information. However, due to the volume of submissions, the Indego team cannot contact each respondent. Please do not contact us to inquire whether you have been selected. If you are selected, we will contact you.

Continue to our Online Intake Form>>

For more information regarding the device, visit Indego.com or email Casey Kandilakis or email Cathy Furbish.

Download the brochure>>

Frequently Asked Questions 

Who can participate in the clinical trials?

Primary criteria for participation in Indego® clinical trials are listed below. Please note that additional criteria must also be met for enrollment, and some participants may require additional testing to determine bone health.

  • Weight less than 250 pounds and can be fit appropriately into the Indego
  • Height from 5'1" to 6'3"
  • No tightness in hips, knees or ankles
  • No evidence of osteoporosis
  • Ability to tolerate being upright without getting dizzy
  • Ability to arrange and pay for all transportation and housing during the testing period. Length of testing periods may vary from one to four weeks.  

How do I sign up to participate in a future Indego® clinical trial?

You must complete the Indego online intake form (above) and submit it electronically. 

Can I use Indego if I have a Baclofen pump, insulin pump, supra-pubic tube, foley catheter tubing, condom catheter tubing or abdominal feeding tube? 

Yes